Labeling them as carcinoids or, worse, well-differentiated neuroendocrine carcinomas, is confusing, particularly to clinicians, and is only marginally supported morphologically
doi: 10.1007/s11011-018-0224-4 226 MirzaAForbesJDZhuFBernsteinCNVan DomselaarGGrahamMet al
& Dhot, P
The classical view of the function of glucagon as a counter-regulatory hormone to insulin, whereby it is secreted by pancreatic -cells in response to hypoglycemia and then acts on the liver to increase glucose production, has not changed [20]
DAC leans toward more sustained-signal effects (water retention, tingling)
The American Diabetes Association (ADA) Standards of Care recommend GLP-1 receptor agonists with proven cardiovascular benefit for patients with established atherosclerotic cardiovascular disease or high cardiovascular risk, regardless of A1C 5